Enovix (ENVX) Research & Development (2020 - 2026)

Enovix (ENVX) has 7 years of Research & Development data on file, last reported at $26.5 million in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 2.31% year-over-year to $26.5 million; the trailing twelve-month figure through Apr 2026 stood at $110.9 million (up 9.13% YoY), and the FY2025 full-year result was $110.3 million, down 11.38% from the prior year.
• Research & Development for Q2 2026 stood at $26.5 million, down from $28.1 million in the prior quarter.
• Across five years, Research & Development topped out at $48.8 million in Q1 2024 and bottomed at $12.7 million in Q2 2022.
• The 5-year median for Research & Development is $25.9 million (2025), against an average of $25.0 million.
• The widest annual swing landed in 2022, when Research & Development jumped 127.79%; it then sank 46.85% in 2025.
• A 5-year view of Research & Development shows it stood at $13.9 million in 2022, then surged by 147.94% to $34.6 million in 2023, then slumped by 35.13% to $22.4 million in 2024, then climbed by 25.15% to $28.1 million in 2025, then fell by 5.51% to $26.5 million in 2026.
• The last three Research & Development figures came in at $26.5 million (Q2 2026), $28.1 million (Q4 2025), and $28.2 million (Q3 2025), per Business Quant data.

Peer Comparison